Telix Pharmaceuticals Limited logo

Telix Pharmaceuticals Limited (TLX)

Market Closed
ASX ASX
- Market Cap
166.8 P/E Ratio
- Div Yield
1.78M Volume
0.2 Eps
Want to track TLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Telix Pharmaceuticals Limited logo
TLX Telix Pharmaceuticals Limited
18 Feb 2026
-
-
Telix Pharmaceuticals Limited logo
TLX Telix Pharmaceuticals Limited
23 Oct 2025
0
-
Telix Pharmaceuticals Limited logo
TLX Telix Pharmaceuticals Limited
21 Aug 2025
-
-
Telix Pharmaceuticals Limited logo
TLX Telix Pharmaceuticals Limited
22 May 2025
-
-
Telix Pharmaceuticals Limited logo
TLX Telix Pharmaceuticals Limited
20 Feb 2025
-
-
Telix Pharmaceuticals Limited logo
TLX Telix Pharmaceuticals Limited
21 Aug 2024
-
-
Telix Pharmaceuticals Limited logo
TLX Telix Pharmaceuticals Limited
22 May 2024
-
-
Telix Pharmaceuticals Limited logo
TLX Telix Pharmaceuticals Limited
15 Apr 2024
-
-
Telix Pharmaceuticals Limited logo
TLX Telix Pharmaceuticals Limited
22 Feb 2024
-
-
Telix Pharmaceuticals Limited logo
TLX Telix Pharmaceuticals Limited
19 Oct 2023
-
-

TLX Earnings Reports FAQ

What is the earnings per share (EPS) for TLX?

The current EPS is 0.2.

What is the company's earnings growth rate?

Telix Pharmaceuticals Limited has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Telix Pharmaceuticals Limited has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Telix Pharmaceuticals Limited are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for TLX at this time, as Telix Pharmaceuticals Limited has no recent EPS data to calculate it.